Long-Term Outcome of Approved Pharmacotherapy for Diabetic Macular Edema: A Review of Randomized Controlled Trials in Fluocinolone Acetonide Implants, Dexamethasone Implants, Aflibercept and Ranibizumab
<p>Diabetic macular edema (DME) is a major sight-threatening cause in diabetic patients. The pathophysiology of macular edema involves both the presence of inflammation and angiogenic stimulant</p><p>regarding vascular endothelial growth factor (VEGF) [1]. Intravitreal injections o...
Saved in:
Main Authors: | Fang-Ting Chen (Author), Jia-Kang Wang (Author) |
---|---|
Format: | Book |
Published: |
Journal of Clinical Research and Ophthalmology - Peertechz Publications,
2015-02-15.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Usefulness of Intravitreal dexamethasone implant in treatment of persistent cystoid macular edema due to Irvine-Gass syndrome
by: Mya Thida Ohn, et al.
Published: (2019) -
Macular Edema: The Current Recommendations for Clinical Practice
Published: (2022) -
Short implants and tooth-implant connections
by: Michel Abbou
Published: (2023) -
Ion Implantation
Published: (2012) -
Implantable Microdevices
by: Qiu, Zhen
Published: (2019)